发明名称 METHOD AND MEDICINAL AGENT FOR INHIBITING REPLICATION OF VIRUS
摘要 PROBLEM TO BE SOLVED: To obtain a new enzymic RNA molecule having an activity for specifically cleaving a specific base sequence of a hepatitis C virus or the like or a genomic RNA or an mRNA or an hnRNA encoded by the virus and useful as an inhibitor of replication, infection and genetic expression of a virus. SOLUTION: This new enzymic RNA molecule has an activity for specifically cleaving a base sequence such as formulae I to III of a hepatitis C virus or a genomic RNA or an mRNA or an hnRNA encoded with the virus and is useful as an inhibitor, etc., of replication, infection and genetic expression of a virus for treatment of viral infection with picornavirus, HIV-1, HIV-2, HBV, papillomavirus, EBV, HTLV-I, HCV, CMV or influenza virus. The enzymic RNA molecule is obtained by selecting a sequence formed of a motif of a hammerhead having a specific substrate binding site complementary to a target viral gene RNA region.
申请公布号 JP2000342285(A) 申请公布日期 2000.12.12
申请号 JP20000132616 申请日期 2000.05.01
申请人 RIBOZYME PHARMACEUTICALS INC 发明人 DRAPER KENNETH G;DUDYCZ LECH W;MCSWIGGEN JAMES A;MACEJAK DENNIS G;HOLECEK JAMES J;MAMONE J ANTHONY
分类号 C12N15/09;A61K31/70;A61K38/00;A61K38/43;A61K39/125;A61K39/13;A61K39/135;A61K39/145;A61K39/21;A61K39/23;A61K39/245;A61K39/29;A61K48/00;A61P1/16;A61P31/12;A61P31/14;A61P31/16;A61P31/18;A61P31/22;A61P35/02;C07H19/06;C07H21/02;C07K14/08;C12N5/10;C12N7/00;C12N9/00;C12N9/22;C12N15/10;C12N15/113;C12N15/85;C12N15/86;C12Q1/68;C12Q1/70;C12R1/91;C12R1/93;G01N33/569 主分类号 C12N15/09
代理机构 代理人
主权项
地址